Remove Pharmaceutical Remove Technology Remove Valuation
article thumbnail

Marvell Technology, Horizon Therapeutics, DoorDash and more

CFO News Room

Marvell Technology Group. Check out the companies making headlines before the bell: Marvell Technology (MRVL) – The chip maker’s stock slid 4.9% ” RBC praises the delivery service’s execution and management but says it is uncomfortable with the current valuation given the potential for order deceleration.

article thumbnail

Six Flags, Rivian, Bumble, Coinbase, Dutch Bros and more

CFO News Room

Apple – Shares of the technology giant gained 8.9% Additionally, Morgan Stanley reiterated it as overweight, noting hardware subscriptions as a key catalyst for moving the market toward a loan-to-value valuation. AstraZeneca – The pharmaceutical company added 6.6% as rates dropped, lifting the broader tech sector.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Chinese Study highlights limitations on IAS 38, accounting for intangible assets

CFO Talks

In a knowledge-based economy, assets like research and development (R&D), software, patents, and technology are becoming more important than physical assets. Like China, our future economic growth depends heavily on innovation and technology-driven industries.

article thumbnail

Apple’s Long Strange Trip to A $2T Valuation

PYMNTS

Apple is on the cusp of a stock market first — becoming the first public company in history to capture a $2 trillion valuation. More than a 20 years later, the company is spitting distance from a $2 trillion valuation. Apple was also a major beneficiary of the advance of mobile networking technology between the years 2000 and 1010.

article thumbnail

Musings on Markets: META Lesson 3: Tell me a story!

CFO News Room

As someone who has spent the last four decades talking, teaching and doing valuation that we have lost our way in valuation. Even as data has become more accessible and our tools have become more powerful, it is my belief that the quality of valuations has degraded over time.

Marketing 130
article thumbnail

Musings on Markets: META Lesson 2: Accounting Inconsistencies and Consequences

CFO News Room

That skewing can affect valuation and pricing judgments about these firms, and correcting accounting inconsistencies is a key step towards leveling the playing field. I believe it is, since failure to do so can have both valuation and pricing consequences.

article thumbnail

META Lesson 3: Tell me a story!

Musings on Markets

Narrative and Value As someone who has spent the last four decades talking, teaching and doing valuation that we have lost our way in valuation. Even as data has become more accessible and our tools have become more powerful, it is my belief that the quality of valuations has degraded over time.